- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Mar 24, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,705 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
4261 | ر.س70.10 | -1.3% | -7.2% | ر.س2.9b | ر.س70.78 | PE18.8x | E10.6% | 2.3% | Transportation | ||
A090430 | ₩118,100.00 | 4.6% | -9.5% | ₩7.3t | ₩160,125.00 | PE45.2x | E30.2% | 0.8% | Household | ||
A009830 | ₩27,250.00 | -1.4% | n/a | ₩4.7t | ₩37,826.09 | PB0.6x | E108.8% | 1.1% | Materials | ||
A006260 | ₩109,700.00 | -0.8% | 45.5% | ₩3.0t | ₩123,571.43 | PB0.7x | E53.3% | 1.5% | Capital Goods | ||
ANNJOO | RM1.16 | 6.4% | 0% | RM651.2m | n/a | PB0.5x | E60.4% | 0% | Materials | ||
A120110 | ₩38,000.00 | 0% | -8.0% | ₩1.1t | ₩59,600.00 | PE20.6x | E46.9% | 3.4% | Materials | ||
A263600 | ₩7,620.00 | -1.4% | -43.5% | ₩121.4b | n/a | PB1.2x | E107.6% | 0.9% | Tech | ||
2493 | CN¥10.83 | -1.9% | -16.1% | CN¥106.6b | CN¥11.89 | PB2.4x | E100.6% | 1.4% | Materials | ||
600515 | CN¥3.56 | -4.8% | -19.1% | CN¥40.7b | n/a | PE43.2x | E29.4% | n/a | Real Estate Management and Development | ||
6327 | JP¥778.00 | -2.6% | 41.7% | JP¥5.8b | JP¥2,000.00 | PE6.3x | E10.6% | 1.0% | Capital Goods | ||
2410 | CN¥12.57 | -7.9% | -75.4% | CN¥20.7b | CN¥22.45 | PE35.1x | E27.2% | 2.3% | Software | ||
YRI | CA$7.88 | -1.7% | 6.3% | CA$7.6b | CA$8.83 | PS3.1x | E79.3% | 2.1% | Materials | ||
RNDB | US$26.99 | 0.1% | 27.0% | US$140.4m | US$27.00 | PB1.6x | E42.8% | 2.2% | Banks | ||
ULE | UK£35.00 | 0.3% | 10.8% | UK£2.5b | UK£32.70 | PE37.5x | E14.9% | 0% | Capital Goods | ||
LOCL | CA$0.17 | 0% | -94.3% | CA$7.3m | n/a | PE-0.2x | E81.9% | n/a | Consumer Retailing | ||
SYNH | US$42.98 | 0.6% | -8.8% | US$4.5b | US$42.63 | PE62.6x | E33.7% | n/a | Pharmaceuticals & Biotech | ||
CELZ | US$5.19 | -3.2% | -2.1% | US$7.2m | US$30.00 | PS797x | E60.9% | n/a | Pharmaceuticals & Biotech | ||
SAR | €11.00 | -1.8% | 70.5% | €748.1m | €9.48 | PE19x | E11.3% | 2.0% | Household | ||
GR1T | UK£0.21 | -2.3% | -36.4% | UK£100.7m | n/a | PS1.9x | E134.0% | 11.3% | Real Estate Management and Development | ||
VCP | UK£2.58 | 10.5% | -48.8% | UK£295.2m | UK£4.28 | PB3.6x | E105.1% | 0% | Consumer Durables | ||
GNRC | US$115.91 | 3.6% | 4.2% | US$7.0b | US$135.82 | PE34.4x | E23.4% | 0% | Capital Goods | ||
BRKL | US$9.51 | 1.9% | -9.9% | US$845.4m | US$12.80 | PB0.7x | E16.5% | 5.7% | Banks | ||
FSTR | US$26.17 | 10.1% | 125.6% | US$287.9m | US$23.00 | PE196.7x | E79.0% | 0% | Capital Goods | ||
GTE | US$6.63 | 6.1% | -11.7% | US$208.7m | US$5.93 | PB0.5x | E44.0% | n/a | Energy |